BUSE 6.63 First Busey Corp $BUSE Hit a 52 week high of 6.68

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

NOV Inc. Announces Scheduled Cash Dividend for Shareholders HOUSTON — NOV Inc. (NYSE: NOV) is excited to share that the Board of Directors has recently made the decision to declare a quarterly cash dividend amounting to $0.075 per share. This dividend is set to be paid on December 19 to all stockholders who are on record as of December 5. The Role of NOV in the Energy...

Enlivex Therapeutics Reports Positive Efficacy Data from Allocetra Trial Nes-Ziona, Israel – Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has announced encouraging interim results from its Phase I/II Allocetra™ trial focusing on patients with moderate to severe knee osteoarthritis. This randomized multi-country study marks a significant step forward in the company’s...

Wing Yip Food Holdings Completes Successful IPO Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) has successfully concluded its initial public offering (IPO), marking a significant milestone for the company. This meat processing company, operating subsidiaries in mainland China, raised approximately US$8.20 million through the offering of 2,050,000 American Depositary...

Alkami Technology's Stock Outlook Enhanced Alkami Technology Inc (NASDAQ: ALKT) has recently captured the attention of investors and analysts alike with its impressive growth trajectory. According to recent reports, the price target for Alkami’s shares has been raised from $35 to $40 by Stephens, indicating a strong belief in the company’s continued success while...

Confidein's Innovative Prayer Ring Initiative In an inspiring move, Confidein, a dedicated technology company at the intersection of faith and innovation, has successfully concluded a $6 million seed funding round. This funding, driven by influential Christian leaders and leading venture capitalists, sets the stage for a transformative campaign to benefit Christian...